$85.99
-2.38-2.69%
At close: -
$85.99
0.000.00%
After Hours: 4:39 PM EDT
DexCom reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of DexCom using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-13 | $0.45 | $0.50 | -10.0 % |
Q3 | 2024-10-24 | $0.45 | $0.43 | 4.65 % |
Q2 | 2024-07-25 | $0.43 | $0.39 | 10.3 % |
Q1 | 2024-04-25 | $0.32 | $0.27 | 18.5 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-13 | $1.11B | $1.10B | 1.27 % |
Q3 | 2024-10-24 | $994.20M | $990.71M | 0.35 % |
Q2 | 2024-07-25 | $1.00B | $1.04B | -3.46 % |
Q1 | 2024-04-25 | $921.00M | $909.24M | 1.29 % |
DexCom (DXCM) is scheduled to report earnings on April 24, 2025. The last reported earnings were for reported on February 13, 2025 for Q4.
The Actual EPS was $0.45, which missed the estimate of $0.50.
The Actual Revenue was $1.1B, which beat the estimate of $1.1B.
Browse earnings estimates, EPS, and revenue on all stocks.